DHS Hungary
Get in touch
DHS Hungary
Get in touch

LAAC

Close

Watchman FLX at Military Hospital

Boston Scientific, LAAC, WatchmanMay 19, 2026231Views0Likes0Comments
A great case from Military Hospital using Boston Scientific WATCHMAN FLX, demonstrating reliable performance in LAA management. The latest results of the Champion AF study showed:  WATCHMAN FLX provided statistically superior protection from bleeding and similar efficacy compared to NOACs in patients with NVAF. #WATCHMANFLX #structuralheart #AFib #cardiology #BostonScientific #DHSHungary #DeliveringHealthcareSolutions

Read More

A new milestone in structural heart innovation, Watchman FLX Pro

Boston Scientific, LAAC, Structural heart, WatchmanMarch 4, 2026291Views0Likes0Comments
The first Watchman FLX Pro implantation in Hungary has been successfully completed deploying the largest 40 mm device with outstanding performance. The implantation achieved an excellent position with optimal sealing, reinforcing the role of LAAC as a powerful alternative care strategy for patients with non-valvular atrial fibrillation who require a non-pharmacological approach to thromboembolic risk…

Read More

Advancing Stroke Prevention: The OPTION Trial

Boston Scientific, Innovation, LAAC, WatchmanJanuary 8, 2025529Views0Likes0Comments
Exciting news in the realm of stroke prevention! The OPTION Trial highlights the safety and effectiveness of left atrial appendage closure (LAAC) using the Watchman FLX™ device as an alternative to oral anticoagulants in patients undergoing AFib ablation. This study reinforces the potential of LAAC to reduce stroke risk while addressing bleeding concerns, offering hope…

Read More

Watchman FLX Device in Atrial Fibrillation Management

Boston Scientific, Cardiology, LAAC, WatchmanAugust 14, 2024432Views0Likes0Comments
The Left Atrial Appendage (LAA) closure is a crucial procedure to reduce the risk of thromboembolism in patients with non-valvular atrial fibrillation. Boston Scientific Watchman FLX device is particularly beneficial for patients who are at an increased risk for stroke and systemic embolism, as identified by CHA2DS2-VASc scores. It's especially valuable for those who are…

Read More

Routine Watchman™ FLX cases at Semmelweis University

Boston Scientific, LAAC, WatchmanMarch 17, 2023326Views0Likes0Comments
Watchman™ FLX implantation at Semmelweis University by Prof. Dr. László GELLÉR, Dr. Zoltán SALLÓ and Dr. Anikó NAGY. Watchman FLX has a robust clinical evidence background: The SURPASS analysis of the NCDR-LAAO Registry™ has data of 16.000+ patients to date and confirms the best-in-class safety profile of Watchman FLX. #dailywork #LAAC #Watchman #BostonScientific #medicaldevice…

Read More

WatchmanFLX™ cases with Prof. Dr. László GELLÉR in Szeged

Boston Scientific, LAAC, WatchmanFebruary 22, 2023351Views0Likes0Comments
Dr. Zoltán RUZSA and Dr. Zoltán JAMBRIK are performing WatchmanFLX cases in Szeged with the professional support of Prof. Dr. László GELLÉR.  Congratulations for the GREAT WORK! The WatchmanFLX device platform is the most studied LAA occluder in the world with proven great performance and very low complication rates. #LAAC #WatchmanFLX #BostonScientific #medicaldevice #healthcareinnovation #DeliveringHealthcareSolutions…

Read More

Watchman™ FLX in use at Semmelweis Heart and Vascular Center

Boston Scientific, LAAC, WatchmanJanuary 30, 2023354Views0Likes0Comments
Left atrial appendage closure with Watchman™ FLX device at Semmelweis Heart and Vascular Center. Implanter: Prof.Dr.László GELLÉR, echocardiographer: Dr. Anikó NAGY. Congratulations for the great work! The WatchmanFLX device platform is the most studied #LAA occluder in the world with proven great performance and very low complication rates. Watchman FLX has a robust clinical evidence…

Read More